TW268948B - - Google Patents
Info
- Publication number
- TW268948B TW268948B TW083102618A TW83102618A TW268948B TW 268948 B TW268948 B TW 268948B TW 083102618 A TW083102618 A TW 083102618A TW 83102618 A TW83102618 A TW 83102618A TW 268948 B TW268948 B TW 268948B
- Authority
- TW
- Taiwan
- Prior art keywords
- lens
- formula
- hydrogen atom
- pharmacologically acceptable
- cataract
- Prior art date
Links
- 208000002177 Cataract Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 108010024636 Glutathione Proteins 0.000 abstract 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000002477 vacuolizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7649093 | 1993-04-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW268948B true TW268948B (OSRAM) | 1996-01-21 |
Family
ID=13606667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW083102618A TW268948B (OSRAM) | 1993-04-02 | 1994-03-25 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5441972A (OSRAM) |
| EP (1) | EP0617960B1 (OSRAM) |
| AT (1) | ATE144140T1 (OSRAM) |
| CA (1) | CA2120300A1 (OSRAM) |
| DE (1) | DE69400723T2 (OSRAM) |
| ES (1) | ES2092844T3 (OSRAM) |
| TW (1) | TW268948B (OSRAM) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
| DK1169322T3 (da) | 1999-03-08 | 2006-03-06 | Medicure Inc | Pyridoxalanaloger til behandling af lidelser foranlediget af vitamin B6-mangel |
| AU5840200A (en) | 1999-07-13 | 2001-01-30 | Medicure Inc. | Treatment of diabetes and related pathologies |
| JP2003507418A (ja) * | 1999-08-24 | 2003-02-25 | メディキュア インターナショナル インコーポレイテッド | 心血管疾患とその関連疾患の治療 |
| ATE389662T1 (de) | 2000-02-29 | 2008-04-15 | Medicure Int Inc | Cardioprotektive phosphonate |
| US7442689B2 (en) * | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
| CA2404329A1 (en) | 2000-03-28 | 2001-10-04 | Medicure International Inc. | Treatment of cerebrovascular disease |
| US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
| JP2004502757A (ja) | 2000-07-07 | 2004-01-29 | メディキュア インターナショナル インコーポレイテッド | ピリドキシンおよびピリドキサール類縁体：心血管系治療薬 |
| US6897228B2 (en) * | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
| US20040121988A1 (en) * | 2001-03-28 | 2004-06-24 | Medicure International Inc. | Treatment of cerebrovascular disease |
| US20040186077A1 (en) * | 2003-03-17 | 2004-09-23 | Medicure International Inc. | Novel heteroaryl phosphonates as cardioprotective agents |
| EP1773370A1 (en) * | 2004-07-07 | 2007-04-18 | Medicure International Inc. | Combination therapies employing platelet aggregation drugs |
| US20070060549A1 (en) * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
| JP2008517956A (ja) * | 2004-10-28 | 2008-05-29 | メディキュア・インターナショナル・インコーポレーテッド | 二重の抗血小板性／抗凝固性ピリドキシン類似体 |
| US7459468B2 (en) * | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
| US20060094749A1 (en) * | 2004-10-28 | 2006-05-04 | Medicure International Inc. | Substituted pyridoxines as anti-platelet agents |
| US20070149485A1 (en) * | 2005-11-28 | 2007-06-28 | Medicure International, Inc. | Selected dosage for the treatment of cardiovascular and related pathologies |
-
1994
- 1994-03-25 TW TW083102618A patent/TW268948B/zh active
- 1994-03-29 DE DE69400723T patent/DE69400723T2/de not_active Expired - Fee Related
- 1994-03-29 ES ES94104943T patent/ES2092844T3/es not_active Expired - Lifetime
- 1994-03-29 EP EP94104943A patent/EP0617960B1/en not_active Expired - Lifetime
- 1994-03-29 AT AT94104943T patent/ATE144140T1/de not_active IP Right Cessation
- 1994-03-30 CA CA002120300A patent/CA2120300A1/en not_active Abandoned
- 1994-04-04 US US08/222,596 patent/US5441972A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5441972A (en) | 1995-08-15 |
| DE69400723T2 (de) | 1997-03-20 |
| EP0617960A1 (en) | 1994-10-05 |
| ES2092844T3 (es) | 1996-12-01 |
| EP0617960B1 (en) | 1996-10-16 |
| CA2120300A1 (en) | 1994-10-03 |
| ATE144140T1 (de) | 1996-11-15 |
| DE69400723D1 (de) | 1996-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW268948B (OSRAM) | ||
| TW326045B (en) | N-alkyl-2-substituted ATP analogues the invention relates to a compound of formula (I) and its pharmaceutically acceptable salt which can be used for inhibition of platelet aggregation. | |
| IL160304A (en) | Compounds and composition for activating peroxisome proliferators-responsive receptor ?? | |
| NO976085D0 (no) | Difenylmetylen-piperidin-derivater | |
| DE60228316D1 (en) | Xanthinoxidaseinhibitoren | |
| EP0787726A4 (OSRAM) | ||
| TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
| HUT36335A (en) | Fungicide compositions containing substituted triazols and process for producing the active agents | |
| GR3018307T3 (en) | ATP analogues. | |
| EA200000614A1 (ru) | 2,3-замещенные соединения индола в качестве ингибиторов сох-2 | |
| IL89475A0 (en) | Biocidal composition comprising imidazole compounds | |
| IL136100A0 (en) | Biphenylamidine derivatives, prodrugs thereof and pharmaceutical compositions containing the same | |
| PL359415A1 (en) | Oxadiazole derivatives having anticancer effects | |
| CA2220024A1 (en) | Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents | |
| EP0469156A4 (en) | Glutathione derivative | |
| EP1426353A4 (en) | 1,3-GLYCERIDE COMPOUND HAVING TWO IODOPHENYL GROUPS | |
| TW207498B (OSRAM) | ||
| PH23966A (en) | Imidazoquinozoline compounds as agent for treatment of nephritis | |
| CA2257772A1 (en) | Bicyclic¬3.1.0|hexanes and related compounds | |
| ATE189813T1 (de) | Prostaglandin-i-analoga |